Value of diffusion-weighted imaging for assessing site-specific response of advanced ovarian cancer to neoadjuvant chemotherapy: Correlation of apparent diffusion coefficients with epithelial and stromal densities on histology

Cancer Biomarkers

Volumn 7, Issue 4-5, 2010, Pages 201-210

  Kyriazi, Stavroula ^a   Nye, Emma ^b   Stamp, Gordon ^b   Collins, David J ^a   Kaye, Stan B ^c   Desouza, Nandita M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

apparent diffusion coefficient; cellularity; Diffusion weighted imaging; ovarian cancer; tumour response

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CELL DENSITY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PARAMETRIC TEST; PERITONEUM METASTASIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; STROMA CELL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DENSITOMETRY; DIFFUSION MAGNETIC RESONANCE IMAGING; EPITHELIAL CELLS; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; STROMAL CELLS;

EID: 79955605456     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0194     Document Type: Article

References (38)

1. Z. Ababneh, H. Beloeil, C.B. Berde, G. Gambarota, S.E. Maier and R.V. Mulkern, Biexponential parameterization of diffu-sion and T2 relaxation decay curves in a rat muscle edema model: decay curve components and water compartments, Magn ResonMed 54 (2005), 524-531. (Pubitemid 41233746)
2. N. Ahmed, K. Abubaker, J. Findlay and M. Quinn, Epithe-lial mesenchymal transition and cancer stem cell-like phe-notypes facilitate chemoresistnce in recurrent ovarian cancer, Curr Cancer Drug Targets 10 (2010), 268-278.
3. N. Avril, S. Sassen, B. Schmalfeldt, J. Naerhing, S. Rutke, W.A. Weber et al., Prediction of response to neoadju-vant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer, J Clin Oncol 23 (2005), 7445-7453. (Pubitemid 46291806)
4. R.F. Barajas, Jr, J.L. Rubenstein, J.S. Chang, J. Hwang and S. Cha, Diffusion-weighted MR imaging derived apparent dif-fusion coefficient is predictive of clinical outcome in prima-ry central nervous system lymphoma, Am J Neuroradiol 131 (2010), 60-66.
5. D. Cooper, A. Schermer and T.T. Sun, Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations, Lab Invest 52 (1985), 243-256. (Pubitemid 15144079)
6. Y Cui, X.P. Zhang, Y.S. Sun, L. Tang and L. Shen, Appar-ent diffusion coefficient: potential imaging biomarker for pre-diction and early detection of response to chemotherapy in hepatic metastases, Radiology 248 (2008), 894-900.
7. B. Czernobilsky, E. Shezen, B. Lifschitz-Mercer, M. Fogel, A. Luzon, N. Jacob et al., Alpha smooth muscle actin (a-SM actin) in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neoplasms, Virchows Archiv B Cell Pathol 57 (1989), 55-61. (Pubitemid 19110365)
8. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford et al., New response evaluation criteria in solidtumours: revised RECIST guideline (version 1.1),EurJ Cancer 45 (2009), 228-247.
9. B.M. Ellingson, M.G. Malkin, S.D. Rand, J.M. Connelly, C Quinsey, P.S. LaViolette et al., Validation offunctional diffu-sion maps (fDMs) as a biomarker for human glioma cellularity, JMagn ResonImaging31 (2010), 538-548.
10. S. Fujii, S. Kakite, K. Nishihara, Y. Kanasaki, T. Harada, J. Ki-gawa et al., Diagnostic accuracy of diffusion-weighted imag-ing in differentiating benign from malignant ovarian lesions, JMagn Reson Imaging 28 (2008), 1149-1156.
11. S. Fujii, E. Matsutsue, Y Kanasaki, Y Kanamori, J. Nakanishi, S. Sugihara et al., Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging, EurRadiol 18 (2008), 18-23. (Pubitemid 351217273)
12. A.C. Guo, T.J. Cummings, R.C. Dash and J.M. Provenzale, Lymphomas and high-grade astrocytomas: comparison of wa-ter diffusibility and histologic characteristics, Radiology 224 (2002), 177-183. (Pubitemid 34680392)
13. V.N. Harry, S.I. Semple, F.J. Gilbert and D.E. Parkin, Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer, Gynecol Oncol 111 (2008), 213-220.
14. Y Hayashida, T. Hirai, S. Morishita, M. Kitajima, R. Muraka-mi, Y Korogi et al., Diffusion-weighted imaging of metastat-ic brain tumors: comparison with histologic type and tumor cellularity, Am J Neuroradiol 27 (2006), 1419-1425. (Pubitemid 44260120)
15. S. Higano, X. Yun, T. Kumabe, M. Watanabe, S. Mugikura, A. Umetsu et al., Malignant astrocytic tumors: clinical impor-tance of apparent diffusion coefficient in prediction of grade and prognosis, Radiology 241 (2006), 839-846. (Pubitemid 46190551)
16. L.G. Hudson, R. Zeineldin and M.S. Stalk, Phenotypic plas-ticity of neoplastic ovarian epithelium: unique cadherin pro-files in tumor progression, Clin Exp Metastasis 25 (2008), 643-655.
17. R. Johansen, L.R. Jensen, J. Rydland, P.E. Goa, K.A. Kvis-tad, T.F. Bathen et al., Predicting survival and early clinical response to primary chemotherapy in patients with locally ad-vanced breast cancer using DCE-MRI, JMagn Reson Imaging 29 (2009), 1300-1307.
18. M. Katayama, T. Masui, S. Kobayashi, T. Ito, H. Sakahara, A. Nozaki et al., Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients? J CompAssist Tomog 26 (2002), 250-256. (Pubitemid 34233373)
19. S. Kyriazi, M. Blackledge, D.J. Collins and N.M. deSouza, Optimising diffusion-weighted imaging in the abdomen and pelvis: comparison of image quality between monopolar and bipolar single-shot spin-echo echo-planar sequences, Eur Ra-diol 20 (2010), 2422-2431.
20. e, and corresponding histologic features, Radiology 255 (2010), 485-494.
21. R.N. Low, C.P. Sebrechts, R.M. Barone and W. Muller, Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathological findings-a feasibility study, Am JRoentgenol 193 (2009), 461-470.
22. L. Mannelli, S. Kim, C.H. Hajdu, J.S. Babb, T.W.I. Clark and B. Taouli, Assessment of tumor necrosis of hepatocellular carcinoma: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver, Am J Roentgenol 193 (2009), 1044-1052.
23. L. Nilsen, A. Fangberget, O. Geier, D.R. Olsen and T. Seier-stad, Diffusion-weighted magnetic resonance imaging for pre-treatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy, Acta Oncol 49 (2010), 354-360.
24. Y Nonomura, M. Yasumoto, R. Yoshimura, K. Haraguchi, S. Ito, T. Akashi et al., Relationship between bone marrow cellularity and apparent diffusion coefficient, J Magn Reson Imaging 13 (2001), 757-760. (Pubitemid 32381854)
25. R.F. Ozols, B.N. Bundy, B.E. Greer, J.M. Fowler, D. Clarke-Pearson, R.A. Burger et al., Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gyneco-logic Oncology Group study, J Clin Oncol 21 (2003), 3194-3200. (Pubitemid 46606249)
26. A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoe-ny, T. Takahara et al., Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommenda-tions, Neoplasia 11 (2009), 102-125.
27. D.M. Patterson, A.R. Padhani and D.J. Collins, Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy, Nat Clin Pract Oncol 5 (2008), 220-233. (Pubitemid 351493681)
28. M.D. Pickles, P. Gibbs, M. Lowry and L.W. Turnbull, Diffu-sion changes precede size reduction in neoadjuvant treatment of breast cancer, Magn Reson Imaging 24 (2006), 843-847. (Pubitemid 44205378)
29. J.M. Provenzale, S. Mukundan and D.P. Barboriak, Diffusion-weighted and perfusion MR imaging for brain tumor charac-terization and assessment of treatment response, Radiology 239 (2006), 623-649.
30. G.J. Rustin, A.E. Nelstrop, P. McClean, M.F. Brady, W.P. McGuire, W.J. Hoskins et al., Defining response of ovarian carcinomato initial chemotherapy accordingto serum CA 125, J Clin Oncol 14 (1996), 1545-1551. (Pubitemid 26134212)
31. E. Sala, A.N. Priest, M. Kataoka, M.J. Graves, M.A. McLean, I. Joubert et al., Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imag-ing: feasibility in metastatic ovarian cancer at 3 Tesla, Eur Radiol 20 (2010), 491-496.
32. O. Skalli, P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen and G. Gabbiani, A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation, J CellBiol 103 (1986), 2787-2796. (Pubitemid 17008024)
33. T. Sugahara, Y Korogi, M. Kochi, I. Ikushima, Y Shige-matu, T. Hirai et al., Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas, JMagn Reson Imaging 9 (1999), 53-60. (Pubitemid 29068231)
34. A. Szafer, J. Zhong and J.C. Gore, Theoretical model for water diffusion intissues,Magn Reson Med33 (1996), 697-712.
35. Thomassin-Naggara, E. Daraï, C.A. Cuenod, L. Fournier, I. Toussaint, C Marsault et al., Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses, Eur Radiol 19 (2009), 1544-1552.
36. O. Togao, S. Doi, M. Kuro-o, T. Masaki, N. Yorioka and M. Takahashi, Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model ofunilateral ureteral obstruction, Radiology 255 (2010), 772-780.
37. R. Woodhams, S. Kakita, H. Hata, K. Iwabuchi, S. Umeoka, C.E. Mountford et al., Diffusion-weighted imaging of muci-nous carcinoma of the breast: evaluation of apparent diffusion coefficient and signal intensity in correlation with histologic findings, Am J Roentgenol 193 (2009), 260-266.
38. J. Zamecnik, The extracellular space and matrix of gliomas, ActaNeuropathol 110 (2005), 435-442. (Pubitemid 41672336)